Singapore markets closed
Straits Times Index
3,181.97 -45.13 (-1.40%) S&P 500
3,693.23 -64.76 (-1.72%) Dow
29,590.41 -486.29 (-1.62%) Nasdaq
10,867.93 -198.87 (-1.80%) BTC-USD
19,120.99 +72.14 (+0.38%) CMC Crypto 200
438.27 -6.27 (-1.41%)
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 227.75 |
| Open | 227.99 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 800 |
| Day's range | 224.56 - 228.61 |
| 52-week range | 198.64 - 258.45 |
| Volume | |
| Avg. volume | 2,637,392 |
| Market cap | 121.413B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 19.30 |
| EPS (TTM) | 11.76 |
| Earnings date | 31 Oct 2022 - 04 Nov 2022 |
| Forward dividend & yield | 7.76 (3.42%) |
| Ex-dividend date | 17 Aug 2022 |
| 1y target est | 253.12 |
- Zacks
AstraZeneca's (AZN) Asthma Drug Tezepelumab Gets Nod in Europe
AstraZeneca's (AZN) Tezspire is the only biologic medicine approved in Europe to treat severe asthma with no phenotype limitation and irrespective of biomarker levels.
- Zacks
Amgen (AMGN) Stock Moves -1.43%: What You Should Know
Amgen (AMGN) closed at $224.46 in the latest trading session, marking a -1.43% move from the prior day.
- Zacks
Novartis (NVS) Unit Posts Positive Results on Prolia Biosimilar
Novartis (NVS) generic unit Sandoz announces that ROSALIA study for its proposed biosimilar of Prolia (denosumab) meets primary endpoints.
© 2022 Yahoo. All rights reserved.
